Biodesix to Present at the Canaccord Genuity 42nd Annual Growth Conference
BOULDER, Colo.—(BUSINESS WIRE)—Aug. 3, 2022— Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung ...
BOULDER, Colo.—(BUSINESS WIRE)—Aug. 3, 2022— Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung ...
Learn more
BOULDER, Colo.—(BUSINESS WIRE)— Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, ...
Learn more
Biodesix, Inc., a Boulder CO-based molecular diagnostics company, and Inivata, a Cambridge, England-based clinical cancer genomics company ...
Learn more